Epic - OmicsDI

Show results for

Unknown (2150)
Genomics (677)
Methylation profiling (299)
Proteomics (147)
Transcriptomics (94)
Genomic (13)
Clinical (11)
Other (9)
Metabolomics (3)

Organisms

Homo sapiens (455)
Allexis (147)
Arabidopsis thaliana (147)
Callinectes sapidus (147)
Cyanophora paradoxa (147)
Ensifer adhaerens (147)
Entamoeba histolytica (147)
Escherichia coli (147)
Histomonas meleagridis (147)
Leishmania major strain Friedlin (147)
Listeria monocytogenes (147)
Lotus japonicus (147)
Medicago truncatula (147)
Methylohalobius crimeensis 10Ki (147)
Mus musculus (147)
Mycobacterium tuberculosis (147)
NEWT:6915 (147)
Oryza sativa Indica Group (147)
Physcomitrium patens (147)
Pseudomonas putida KT2440 (147)
Rattus norvegicus (147)
Saccharomyces cerevisiae (147)
Schizosaccharomyces pombe (147)
Mus musculus (14)
Drosophila melanogaster (4)
Yersinia enterocolitica (1)
Arabidopsis thaliana (1)
Macaca fascicularis (1)
synthetic construct (1)
Rattus norvegicus (1)

Organisms

Homo sapiens (552)
Mus musculus (15)
Pseudomonas aeruginosa (6)
Drosophila melanogaster (2)
Pan troglodytes (1)
Macaca fascicularis (1)
Arabidopsis thaliana (1)
synthetic construct (1)

Repository

ENA (607)
geo (346)
pride (147)
biostudies-arrayexpress (66)
EGA (58)
dbGaP (13)
MetaboLights (2)
EVA (1)
MetabolomicsWorkbench (1)
NODE (1)

Tissue

Cell culture (27)
Epithelial cell (9)
Permanent cell line cell (7)
HeLa cell (6)
Blood (5)
Brain (5)
Colon (5)
Heart (5)
Kidney (5)
Pancreas (5)
Blood plasma (4)
Breast (4)
Lung (4)
Cell suspension culture (3)
JURKAT cell (3)
Liver (3)
B cell (2)
Blood serum (2)
Breast cancer cell (2)
Hepatocyte (2)
Leaf (2)
Leukemia cell (2)
Milk (2)
Myeloid cell (2)
Ovary (2)
Spleen (2)
T cell (2)
Thigh muscle (2)
Blood (1)
Colorectum (1)

Disease

Breast cancer (6)
Acute leukemia (4)
COVID-19 (4)
Cervix carcinoma (4)
Colon cancer (4)
Brain cancer (3)
Colorectal Neoplasms (2)
Colorectal cancer (2)
Peritoneal metastasis from colorectal or appendiceal cancer (1)
Peritoneal Diseases (1)
Castrate Resistant Prostate Cancer (1)
Prostate Cancer (1)
Fever (1)
Prostatic Neoplasms (1)
Carcinoma (1)
Colorectal cancer (1)
Neoplasms (1)
Parkinsons disease (1)
Acute myeloid leukemia (1)
Anal canal squamous cell carcinoma (1)
Brain glioblastoma multiforme (1)
Cardiovascular system disease (1)
Colorectal adenocarcinoma (1)
Disease free (1)
Hepatocellular carcinoma (1)
Immunoglobulin light chain amyloidosis (1)
Inflammation (1)
Lung adenocarcinoma (1)
Malignant neoplasm of ovary (1)
Melanoma (1)

Technology Type

Mass Spectrometry (148)
Shotgun proteomics (89)
Chemical cross-linking coupled with mass spectrometry proteomics (23)
SWATH MS (17)
Affinity purification coupled with mass spectrometry proteomics (16)
Bottom-up proteomics (11)
Data-dependent acquisition (8)
Top-down proteomics (7)
All-ion fragmentation (4)
Gel-based experiment (4)
Data-independent acquisition (3)
Mass spectrometry (2)
MSE (2)
IlluminaHumanMethylationEPIC (1)
EI (1)
ESI (1)
SRM/MRM (1)

Instrument Platform

Illumina iScan (5)
NextSeq 500 (2)
Q Exactive (2)
Dell PRECISION T7500 (1)
MethylationEPIC BeadChip (Illumina, San Diego, CA, USA) (1)
Illumina Hybridisation Oven (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 2000 (1)
- (1)

Publication Date

2021 (94)
2022 (84)
2020 (83)
2024 (67)
2023 (55)
2026 (51)
2025 (46)
2019 (27)
2018 (24)
2017 (12)
2016 (7)
2013 (4)
2012 (4)
2015 (2)
2010 (1)
2008 (1)

CHEBI ID

CHEBI:10033 (2)
CHEBI:133583 (2)
CHEBI:133565 (2)
CHEBI:9671 (2)
CHEBI:73018 (2)
CHEBI:58128 (2)
CHEBI:166739 (2)
CHEBI:48929 (2)
CHEBI:9307 (2)
CHEBI:133026 (2)
CHEBI:8776 (2)
CHEBI:604731 (2)
CHEBI:133706 (2)
CHEBI:132994 (2)
CHEBI:88765 (2)
CHEBI:8087 (2)
CHEBI:7936 (2)
CHEBI:28315 (2)
CHEBI:133089 (2)
CHEBI:90344 (2)
CHEBI:86910 (2)
CHEBI:133430 (2)
CHEBI:178069 (2)
CHEBI:133532 (2)
CHEBI:61993 (2)
CHEBI:73072 (2)
CHEBI:25013 (2)
CHEBI:133594 (2)
CHEBI:71062 (2)
CHEBI:5778 (2)

Metabolite Name

Verapamil (2)
Vanillic alcohol sulfate (2)
Valerate (2)
Umbelliferone sulfate (2)
Tyramine O-sulfate (2)
Triamterene (2)
Thymol sulfate (2)
Theophylline (2)
Theobromine (2)
Theanine (2)
Taurolithocholate 3-sulfate (2)
Taurocholenate sulfate (2)
Tartarate (2)
Sulfate* (2)
Succinimide (2)
Salicyluric glucuronide* (2)
Saccharin (2)
S-allylcysteine (2)
Ranitidine (2)
Quinine (2)
Pyrraline (2)
Pyroglutamine* (2)
Propyl 4-hydroxybenzoate sulfate (2)
Pregnenolone sulfate (2)
Pregnen-diol disulfate* (2)
Pregnanediol-3-glucuronide (2)
Phenylalanylphenylalanine (2)
Phenylacetylglutamine (2)
Phenylacetate (2)
Paroxetine (2)

First Public Date

2025 (94)
2024 (87)
2022 (73)
2023 (71)
2020 (71)
2021 (67)
2026 (65)
2019 (35)
2018 (26)
2017 (8)
2014 (7)
2016 (3)

Classification

bacteria (6)

Modification

N6 (2)

Study status

Recruiting (5)
Completed (3)
Terminated (1)
Withdrawn (1)
Not yet recruiting (1)

Study type

Methylation profiling by array (47)
Interventional (10)
Human - Methylation microarray (6)
Transcription profiling by array (4)
Cell line - Methylation microarray (2)
Transcription profiling by tiling array (2)
Human - Two-color microarray (1)
ChIP-chip by tiling array (1)
DNA-seq (1)
RNA-seq of total RNA (1)
RNA-seq of coding RNA (1)
Observational (1)

Release Date

2025 (297)
2022 (297)
2023 (268)
2021 (265)
2024 (257)
2020 (173)
2019 (143)
2018 (105)
2017 (85)
2016 (67)
2015 (57)
2026 (55)
2014 (43)
2013 (32)
2012 (26)
2011 (16)
2009 (10)
2010 (9)
2008 (5)
2007 (3)
2005 (2)
2006 (1)

Lab affiliation

Proteomics program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark (4)
Chair of Proteomics and Bioanalytics, Technical University of Munich, Germany (3)
European Institute of Oncology (3)
BioBix, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, Ghent, Belgium (2)
Centre for Applied Bioanthropology, Institute for Anthropological Research, Zagreb, Croatia (2)
European Institute of Oncology, Milan (2)
Head of Cell Signaling and Clinical Proteomics Group. IIS Biobizkaia. Ikerbasque. (2)
Industrial Biotechnology & Biocatalysis Group, Biotechnology Laboratory, School of Chemical Engineering, National Technical University of Athens, Athens, Greece (2)
Proteomics program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark (2)
Technical University in Munich (2)
Technical University of Munich, Germany (2)
"Chair of Proteomics and Bioanalytics, Technical University of Munich, Germany" (1)
1. Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands. 2. Netherlands Proteomics Centre, Padualaan 8, 3584 CH Utrecht, The Netherlands. (1)
1Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto, Ontario M5S 3E1, Canada 2Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada Departments of Biochemistry and Biology, Boston University, 71 E. Concord St, Boston, MA 02118, USA (1)
1Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria (1)
Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS) School of Life Sciences Technical University of Munich (TUM) Gregor-Mendel-Straße 4 85354 Freising GERMANY (1)
Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS) Technical University Munich (TUM) Gregor-Mendel-Straße 4 85354 Freising (1)
Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS) Technical University Munich Gregor-Mendel-Straße 4 85354 Freising GERMANY (1)
Biocev-Institute of Microbiology, The Czech Academy of Sciences, Prague, Czech Republic (1)
Biognosys AG (1)
Biognosys AG, Schlieren, Switzerland (1)
Biognosys AG, Schlieren, Switzerland (Dr. Lukas Reiter, lukas.reiter@biognosys.com) Institute of Molecular System Biology, ETH Zurich, Zurich, Switzerland (Prof. Dr. Paola Picotti, picotti@imsb.biol.ethz.ch) (1)
Biomolecular Mass Spectrometry Pharmaceutical Sciences Utrecht University (1)
Biomolecular Mass Spectrometry and Proteomics Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences Utrecht University (1)
Biomolecular Mass Spectrometry and Proteomics Bijvoet Center for Biomolecular Research and Utrecht Institute of Pharmaceutical Sciences Padualaan 8 3584 CH Utrecht Utrecht University The Netherlands (1)
Biomolecular Mass Spectrometry and Proteomics group, Utrecht University (1)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht (1)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht Netherlands Proteomics Center, Padualaan 8, 3584 CH Utrecht, The Netherlands (1)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, 3584 CH Utrecht, The Netherlands (1)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, 3584 CH, Utrecht, The Netherlands and Netherlands Proteomics Center, Padualaan 8, 3584 CH, Utrecht, The Netherlands (1)

Location

United States (3)
Australia (2)
United Kingdom (2)
India (1)
Sweden (1)
Canada (1)
Japan (1)

Keyword

Hyperthermic intraperitoneal chemotherapy (2)
Fluorouracil (2)
ICARuS (1)
Intraperitoneal Chemotherapy (1)
Optimal Surgical Debulking (1)
12-289 (1)
Early post-operative intraperitoneal chemotherapy (1)
MEPIC (1)
Obturator (1)
Urinary (1)
Sexual (1)
PROM (1)
EPIC (1)
Bowel (1)
Floxuridine (FUDR) (1)
Intraperitoneal chemotherapy (1)
Mitomycins (1)
Mitomycin (1)
Cytoreductive surgery (1)
Radiotherapy (1)
Prostate (1)
Irinotecan (1)
Leucovorin (1)
Oxaliplatin (1)

Previous page
1 / 341
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 341
Next page

Sort by:

Relevance

Page size

Rare and common genetic determinants of metabolic individuality and their effects on human health (EPIC-Norfolk study assays)

Garrod’s concept of “chemical individuality” has contributed to comprehension of the molecular origins of human diseases. Untargeted high-throughput metabolomic technologies provide an in-depth snapshot of human metabolism at scale. We studied the genetic architecture of the human plasma metabolo...

2022-09-09 | MTBLS833 | MetaboLights

Searching for prognostic biomarkers of Parkinson´s Disease development in the Spanish EPIC cohort through a multiplatform metabolomics approach

Not available

ORGANISM(S): Homo sapiens

ST001814 | MetabolomicsWorkbench

EPIC

PRJEB94054 | ENA

EPIC: Software Toolkit for Elution Profile-Based Inference of Protein Complexes

Heteromeric protein complexes are key macromolecular machines of the cell, but their description remains incomplete. We previously reported an experimental strategy for global characterization of native protein assemblies based on chromatographic fractionation of biological extracts coupled to preci...

ORGANISM(S): Caenorhabditis elegans

2019-07-16 | PXD011182 | Pride

EPIC-HPS

PRJNA684138 | ENA

circSHAPE-MaP of EPIC

PRJNA1045579 | ENA

Exercise Training Effects on Human Skeletal Muscle DNA Methylation

This study aimed to determine skeletal muscle DNA methylation changes in a cohort of volunteers with a range of insulin sensitivities following 8-weeks of supervised exercise training. We studied 13 sedentary participants (5M/8F, 34.6 ± 3.1 years) and performed euglycemic hyperinsulinemic clamps wit...

ORGANISM(S): Homo sapiens

2022-03-01 | E-MTAB-11282 | biostudies-arrayexpress

EPIC

EPIC array data from 72 tumor samples with muscle invasive bladder cancer.

EGAD00010001921 | EGA

Uli-Epic: A cutting-edge library construction strategy for profiling ultra-limited RNA modifications [Uli-Epic GLORI]

PRJNA1162040 | ENA

Illumina Infinium HumanMethylation EPIC beadchip profiling of 31 pediatric histologically defined anaplastic pilocytic astrocytoma

We used the Illumina Infinium HumanMethylation EPIC beadchip array to profile 31 pediatric tumors with the histological diagnosis of anaplastic pilocytic astrocyoma (PA). PA with anaplasia has been defined in the 2016 WHO classification as a tumor with PA morphology and >4 mitoses per 10 HPF, with o...

ORGANISM(S): Homo sapiens

2019-11-08 | E-MTAB-8390 | biostudies-arrayexpress

Previous page
1 / 341
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 341
Next page

Sort by:

Relevance

Page size

3403 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Classification

Modification

Study status

Study type

Release Date

Lab affiliation

Location

Tags

Keyword

OmicsDI is part of the ELIXIR infrastructure

Tweets